Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product
Launched by PROKIDNEY · Jan 17, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This observational extension study is a multi-center, prospective, non-therapeutic study, where up to 50 participants who have been enrolled and dosed with Renal Autologous Cell Therapy in previous interventional clinical studies (REGEN-007, REGEN-006, REGEN-015) will be monitored for up to five years with alternating in clinic and phone visits.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The participant must have received REACT in a previous trial (REGEN-006, REGEN- 007, and REGEN-015) for the treatment of chronic kidney disease and completed an end of study visit in their previous trial per protocol.
- • The participant is willing and able to cooperate with all aspects of the protocol.
- • The participant is willing and able to provide signed informed consent.
- Exclusion Criteria:
- • • Participant did not receive REACT in a previous trial for the treatment of chronic kidney disease
About Prokidney
Prokidney is a clinical research organization dedicated to advancing innovative therapies for chronic kidney disease (CKD) and related conditions. With a focus on developing cell-based regenerative treatments, Prokidney aims to restore kidney function and improve patient outcomes. The organization leverages cutting-edge science and a robust clinical development pipeline to address unmet medical needs in nephrology, fostering collaboration with healthcare professionals and research institutions. Committed to excellence and patient-centered care, Prokidney strives to transform the landscape of kidney disease management through rigorous clinical trials and evidence-based solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Meridian, Idaho, United States
Patients applied
Trial Officials
Study Director
Study Director
Prokidney
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported